Skip to main content
Message Font: Serif | Sans-Serif
No. of Recommendations: 1

I do not agree with you on this one. I can see from your reply that you are not the doctor I asked for. Novogen is a lot more than a producer of some new-age herbal food-supplement. Of course the level of cholesterol in the blood is important for the maintenance of the arteries. The amount of cholesterol we eat counts only for a very limited part of it. Your great-aunt probably had a natural low cholesterol-level, or perhaps she also ate a lot of beans?

Just because the isoflavones come from plants, that doesn't mean that you can't make potent drugs with them. Most research in this area concentrates on isoflavones derived from Soy. A quick search brings up many serious studies, by big companies, in particular on genistein. Novogen works with red clover, which contains four different isoflavones. They have learned how different combinations have different effects. I suppose the article that I'm looking for suggested that a particular combination didn't change cholesterol levels significantly. That's quite possible, but that doesn't mean that other combinations don't work either.

While I agree that there haven't been enough studies done yet and certainly not enough published, I think the results so far are promising enough to bet my money on. You mention Biota as a respected company with an FDA approved product. BTA is trading at $4.60 as I'm writing this, lower than two years ago or one year ago and half of its all time high. That is not the kind of investment I'm looking for. Apart from short time trading, the only way to make money on Biota was to get in long before they were near approval; i.e. when they were in the phase Novogen is in now.

Novogen has discovered a completely new class of compounds, which they call phenolic hormones. These compounds seem to be involved in many of the bodies regulating mechanisms. Pre clinical research has provided a pipeline full of possible applications. The first is an anti-cancer compound, Phenoxodiol, which is currently in Phase 1b of human clinical testing. Submission to FDA for approval to conduct clinical trials in the US is being prepared.

I really believe they are on to something and I'm not the only one. Did you notice the ease with which they can apparently convince institutions to buy millions of shares at market price, whenever they need new cash?

So many trials are going on in so many universities, hospitals and research centers; eventually they will be proven and accepted by the broader scientific community. Then it will be a bit too late to buy their shares. Of course there is a risk and it may take a while, but now is the time to buy if you want more than market returns from your investment.


Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.